This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davidson, R. Articles by Wilcox, C. S. Search for Related Content PubMed PubMed Citation Articles by Davidson, R. Articles by Wilcox, C. S.

Hypertension, Vol 18, 299-303, Copyright © 1991 by American Heart Association

ARTICLES

Diagnostic usefulness of renal scanning after angiotensin converting enzyme inhibitors

R Davidson and CS Wilcox

Radioisotopic renal scanning after angiotensin converting enzyme inhibition (ACEI) has proven to be an exciting area for research. The biologic activity of markers such as DTPA and hippuran, when combined with the physiological effects of ACEI, may provide noninvasive methods of diagnosing both renal artery stenosis and renovascular hypertension. Recent investigators have demonstrated that the sensitivities and specificities of these tests may vary widely; these differences are probably due to variations in study design, patient population, diagnostic criteria, and outcome measurements. We have reviewed these studies and discuss these possible sources of variation and their impact on the clinical usefulness of these diagnostic tests, especially in relation to the prevalence of disease in the population. Current results suggest that the post-ACEI DTPA scan is relatively accurate in the diagnosis of renal artery stenosis, with sensitivity generally greater than 90% and specificity around 95%. However, the best results in predicting the response to angioplasty or surgery in patients with renal artery stenosis have been with the use of post-ACEI hippuran in combination with furosemide (sensitivity, 96%; specificity, 95%). With confirmation of these findings and continued investigation, it is expected that accurate noninvasive tests will be available for widespread clinical use in the near future.

This article has been cited by other articles:

				F. Takahashi, N. Hasebe, Y. Ogawa, S. Tsuji, S. Kido, T. Aburano, and K. Kikuchi Renal Artery Stenosis Emerged After Angiotensin-Converting Enzyme Inhibitor Treatment for Myocardial Infarction: A Case Report Angiology, May 1, 2005; 56(3): 347 - 350. [Abstract] [PDF]

				K. A. Collins and R. J. Gusberg Current Perspectives on the Role of Captopril Imaging in the Diagnosis of Renovascular Disease Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 2000; 13(1): 43 - 69. [Abstract] [PDF]

				L. S. Malatino, G. Polizzi, M. Garozzo, F. Rapisarda, P. Fatuzzo, I. Bellanuova, A. Cataliotti, A. Brozzetti, S. Neri, P. A. Malfa, et al. Diagnosis of Renovascular Disease by Extra- and Intrarenal Doppler Parameters Angiology, October 1, 1998; 49(10): 707 - 721. [Abstract] [PDF]

				B. C. van Jaarsveld, P. Krijnen, F. H. M. Derkx, H. Y. Oei, C. T. Postma, and M. A. D. H. Schalekamp The Place of Renal Scintigraphy in the Diagnosis of Renal Artery Stenosis: Fifteen Years of Clinical Experience Arch Intern Med, June 9, 1997; 157(11): 1226 - 1234. [Abstract] [PDF]

				W. J. Elliott, W. B. Martin, and M. B. Murphy Comparison of Two Noninvasive Screening Tests for Renovascular Hypertension Arch Intern Med, March 22, 1993; 153(6): 755 - 764. [Abstract] [PDF]

				R. A. Davidson and C. S. Wilcox Newer Tests for the Diagnosis of Renovascular Disease JAMA, December 16, 1992; 268(23): 3353 - 3358. [Abstract] [PDF]